Boards want to pay their own CEO more than their rivals. This will naturally create an upward bias in pay, said Charles Elson, UD in a 2012 paper.
Faculty & Research
Lerner in the Media
The mergers game is a very long dance. Once they've established something like this and put this much effort into it, they seldom just walk away," said Charles Elson, UD
James Butkiewicz, economics, discussed the direct effects of Pfizer's potential acquisition of Astra Zeneca.
The Blue Hen Investment Club, which manages $1.5 million of UD’s endowment, is highlighted in the article.
“A decade ago, directors were seen but not heard,” says Charles Elson at UD. “The world has changed. Investors are withholding against director candidates."
Charles Elson, a corporate governance expert at the University of Delaware, said resounding shareholder defeats of company-backed plans are unusual.
James Butkiewicz, a professor of economics at the University of Delaware, “There are two outcomes: either there will be fewer AstraZeneca’ jobs in Delaware, or there will be none.”
Charles Elson, director, Weinberg Center for Corporate Governance, discussed stock awards as CEO compensation.
Dan Freeman, director of the Horn Program in Entrepreneurship, was cited for leading efforts to launch the Venture Development Center at UD.
Op-ed piece cites a study conducted at UD during the annual Economic Forecast sponsored by Lyons Companies and the Center for Education and Entrepreneurship that shows expectations of an improving economy.